Efficacy

The Endeavor stent provides sustained and consistent reduction in (TLR).

  • Demonstrated superior reduction in TLR rate vs. Driver sustained out to three years (p=<.001)1
  • Clinical efficacy proven against Cypher® and Taxus®2
  • Consistent results across trials3
TLR Event-Free Survival at 3 years

1ENDEAVOR II clinical trial - Endeavor: n=598, Driver: n=599. p-values are unadjusted for multiple comparisons. Kaplan-Meier analysis.
2ENDEAVOR III clinical trial - Endeavor: n=321; Cypher: n=113 and ENDEAVOR IV clinical trial - Endeavor: n=758; Taxus: n=749.
3ENDEAVO R I, II, II CA, III, IV, Japan trials and E-Five registry
Data on file at Medtronic, Inc.
Cypher is a registered trademark of J&J/Cordis Corp.
Taxus is a registered trademart of Boston Scientific Corporation



©Medtronic, Inc. 2007